Microbot Medical Inc. (FRA:CY9D)
2.300
+0.329 (16.69%)
At close: Nov 28, 2025
Microbot Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 6.7 | 3.11 | 2.47 | 2.44 | 13.49 | 19.65 | Upgrade |
Short-Term Investments | 73.45 | 2.36 | 3.92 | 5.76 | 2 | 5 | Upgrade |
Cash & Short-Term Investments | 80.16 | 5.47 | 6.39 | 8.21 | 15.49 | 24.65 | Upgrade |
Cash Growth | 1747.81% | -14.33% | -22.18% | -47.04% | -37.15% | -21.23% | Upgrade |
Other Receivables | - | 0.09 | 1.4 | 0.1 | 0.17 | 0.07 | Upgrade |
Receivables | - | 0.09 | 1.4 | 0.1 | 0.17 | 0.34 | Upgrade |
Prepaid Expenses | 0.57 | 0.21 | 0.09 | 0.43 | 0.13 | 0.18 | Upgrade |
Restricted Cash | 0.05 | 0.05 | 0.05 | 0.08 | 0.09 | 0.08 | Upgrade |
Total Current Assets | 80.79 | 5.82 | 7.92 | 8.81 | 15.88 | 25.25 | Upgrade |
Property, Plant & Equipment | 0.98 | 0.21 | 0.41 | 0.72 | 0.89 | 1.03 | Upgrade |
Total Assets | 81.76 | 6.03 | 8.33 | 9.54 | 16.77 | 26.28 | Upgrade |
Accounts Payable | 0.51 | 0.17 | 0.36 | 0.12 | 0.28 | 0.28 | Upgrade |
Accrued Expenses | 2.13 | 2.23 | 1.03 | 1.67 | 1.43 | 0.88 | Upgrade |
Current Portion of Leases | 0.3 | 0.07 | 0.19 | 0.28 | 0.28 | 0.19 | Upgrade |
Other Current Liabilities | - | - | 2.21 | - | - | - | Upgrade |
Total Current Liabilities | 2.93 | 2.46 | 3.79 | 2.07 | 1.98 | 1.35 | Upgrade |
Long-Term Leases | 0.6 | 0.04 | 0.04 | 0.18 | 0.4 | 0.63 | Upgrade |
Total Liabilities | 3.54 | 2.5 | 3.83 | 2.25 | 2.39 | 1.97 | Upgrade |
Common Stock | 0.66 | 0.2 | 0.12 | 0.08 | 0.07 | 0.07 | Upgrade |
Additional Paid-In Capital | 178.19 | 94.28 | 83.88 | 75.97 | 69.9 | 68.52 | Upgrade |
Retained Earnings | -100.62 | -90.94 | -79.5 | -68.76 | -55.59 | -44.28 | Upgrade |
Shareholders' Equity | 78.22 | 3.53 | 4.5 | 7.29 | 14.38 | 24.31 | Upgrade |
Total Liabilities & Equity | 81.76 | 6.03 | 8.33 | 9.54 | 16.77 | 26.28 | Upgrade |
Total Debt | 0.9 | 0.11 | 0.23 | 0.46 | 0.68 | 0.81 | Upgrade |
Net Cash (Debt) | 79.26 | 5.36 | 6.15 | 7.74 | 14.81 | 23.84 | Upgrade |
Net Cash Growth | 1767.55% | -12.92% | -20.52% | -47.73% | -37.86% | -21.57% | Upgrade |
Net Cash Per Share | 2.38 | 0.34 | 0.60 | 1.07 | 2.08 | 3.35 | Upgrade |
Filing Date Shares Outstanding | 67.16 | 34.74 | 14.4 | 8.13 | 7.11 | 7.11 | Upgrade |
Total Common Shares Outstanding | 65.83 | 19.4 | 11.71 | 7.89 | 7.11 | 7.11 | Upgrade |
Working Capital | 77.85 | 3.36 | 4.14 | 6.75 | 13.9 | 23.91 | Upgrade |
Book Value Per Share | 1.19 | 0.18 | 0.38 | 0.92 | 2.02 | 3.42 | Upgrade |
Tangible Book Value | 78.22 | 3.53 | 4.5 | 7.29 | 14.38 | 24.31 | Upgrade |
Tangible Book Value Per Share | 1.19 | 0.18 | 0.38 | 0.92 | 2.02 | 3.42 | Upgrade |
Machinery | - | 0.44 | 0.41 | 0.38 | 0.3 | 0.25 | Upgrade |
Leasehold Improvements | - | 0.23 | 0.23 | 0.23 | 0.23 | 0.21 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.